Collateral Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Tuberculosis Control in Jiangsu Province, China
Qiao Liu, Peng Lü, Ye Shen, Changwei Li, Jianming Wang, Limei Zhu, Wei Lu, Leonardo Martínez
Clinical Infectious Diseases · 2020-08
Abstract
The coronavirus disease 2019 (COVID-19) pandemic may impede global tuberculosis elimination goals. In Jiangsu Province, China, tuberculosis notifications dropped 52% in 2020 compared to 2015-2019. Treatment completion and screening for drug resistance decreased continuously in 2020. Urgent attention must be paid to tuberculosis control efforts during and after the COVID-19 pandemic.
MeSH terms
- Pandemic
- Medicine
- Coronavirus disease 2019 (COVID-19)
- Tuberculosis
- Coronavirus
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- China
- Disease
- 2019-20 coronavirus outbreak
- Collateral damage
- Virology
- Environmental health